Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 55

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 55
---
 non-solicitationprovisions, among others contained in the Divestiture Agreement, could discourage a third party that might have an interest in acquiring all or substantially all of our assets or our common stock from considering or proposing such an acquisition, even if that party were prepared to pay consideration with a higher value than the consideration paid by Kaken. - 37 -

Aadi will incur significant expenses in connection with the Divestiture, regardless of whether the Divestiture is completed.

We expect to incur significant expenses related to the Divestiture. These expenses include, but are not limited to,
financial advisory and opinion fees and expenses, legal fees, accounting fees and expenses, certain employee expenses, filing fees, printing expenses and other related fees and expenses. Many of these expenses will be payable by us regardless of
whether the Divestiture is completed.

Further, pursuant to the terms of the Divestiture Agreement, between the date of the Divestiture Agreement and the
date of the completion of the Divestiture, and thereafter following the date of the closing of the Divestiture, Aadi and Kaken must negotiate in good faith and use reasonable best efforts to enter into and execute the Transition Services Agreement,
on such terms as may be mutually agreed by Aadi and Kaken. The Transition Services Agreement will provide that from and after the closing of the Divestiture, Aadi will make available to Kaken for a period of not less than three months but not more
than six months following the date of the closing of the Divestiture, such services and resources (including the time of certain of its executive management and employees) that in each case Aadi has access to and are within Aadi’s control, as
Kaken may reasonably require in order to be able to conduct and operate the FYARRO Business following the closing of the Divestiture in substantially the same or a similar manner as the manner in which it was operated prior to the completion of the
Divestiture. Performance of our obligations under the Transition Services Agreement will incur significant financial costs and the focus and attention of our management and employee resources may be diverted from our remaining business and ADC
Programs.

Our executive officers and directors may have interests in the Divestiture other than, or in addition to, the interests of our stockholders generally.

Members of our board of directors and our executive officers may have interests in the Divestiture that are different
from, or are in addition to, the interests of our stockholders generally. Our board